awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38068534-0AA8982D-7FD0-4404-8BD9-C8EB7312D6D5
Q38068534-0AA8982D-7FD0-4404-8BD9-C8EB7312D6D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38068534-0AA8982D-7FD0-4404-8BD9-C8EB7312D6D5
Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
P2860
Q38068534-0AA8982D-7FD0-4404-8BD9-C8EB7312D6D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38068534-0AA8982D-7FD0-4404-8BD9-C8EB7312D6D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
141ac3787af0a72086a38e05cb68872814760716
P2860
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.